Post Archive by Day

The Sabin Vaccine Institute today announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA) had awarded it a multi-year contract with funding potential for up to $214 million to advance the development and production of Ebola Sudan and Marburg virus diseases vaccines.
As of January 12, 2023, no licensed vaccines against Ebola Sudan and Marburg viruses exist.
However, if approved, these vaccines could be used as part of ongoing U.S. preparedness efforts and in response to future global outbreaks.

Women can give their babies protection against whooping cough (pertussis) before their little ones are even born, says the U.S. Centers for Disease Control and Prevention (CDC).
The U.S. Food and Drug Administration (FDA) recently approved a second, safe vaccine that prevents whooping cough from achieving that goal.
When these (Tdap) vaccines are given during pregnancy, it increases antibodies in the mother, which are transferred to the developing fetus.

The Coalition for Epidemic Preparedness Innovations (CEPI) and Tiba Biotech today announced a new partnership to evaluate next-generation RNA vaccine platform technology.
Through a Call for Proposals issued in January 2022, CEPI sought to advance novel RNA platform technologies based on high-impact innovations that could make RNA vaccines more effective.